About
We develop innovative solutions based on the analysis of exhaled biomarkers as useful tools for the diagnosis, prognosis, and monitoring of various respiratory diseases, among which asthma stands out. We currently have the evernoa BASE device, which allows to measure airway inflammation by detecting Nitric Oxide through a simple and non-invasive test.
Technologies
Bootstrap Framework
Apache
Google Tag Manager
Mobile Friendly
Keywords
patentes
asthma diagnostic & management
biomarcadores exhalados
manufacturing
iso13485
oxido nitrico
comercializacion
patents
commercialization
id
ehealth
nitric oxide
rampd
exhaled biomarkers
medical devices
fabricacion
dispositivos medicos
rd
feno
medical equipment manufacturing
exhaled nitric oxide analysis
biomarker detection technology
biotechnology
innovation
disease monitoring
biomarkers
regulatory compliance
medical equipment and supplies manufacturing
respiratory health
product development
Company Information
-
Employees 5
-
Founded 2015
-
Total Funding $339794
Location
Calle de Tajonar, Navarre, Spain, 31006
